FGF21 levels in breast cancer
Part of Cancer, Skin clinical trials.
This trial is studying the role of a protein called FGF21 in women recently diagnosed with breast cancer. It aims to understand how FGF21 relates to breast cancer, which may help in future treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman diagnosed with breast cancer based on standard tests.
- You are being treated at the South Egypt Cancer Institute.
- You do not have any other type of cancer at the same time.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests a new PET/CT imaging tracer to see how well it can detect breast cancer spots in the body. It may help doctors learn where breast cancer is and how imaging could work better in the future.
This trial tests a new drug called GNC-077 for people with advanced breast cancer or other solid tumors that have spread. It aims to see if the drug is safe and effective.
This study looks at specific molecules in the body that can change how your genes work (epigenetic mediators) in women who have just been diagnosed with breast cancer. The goal is to understand these markers better, which could help improve treatment in the future.
This study tests a new treatment called GcMAF (Soloways) for women with metastatic breast cancer. It is a placebo-controlled pilot study, meaning some participants will get the study drug and some will get an inactive pill. The goal is to see if GcMAF can help control the cancer.
This study looks at a protein called PIG-U in breast cancer tissue to understand its role in the disease. If you have breast cancer and haven't had chemotherapy or radiation yet, you may be able to join.
This study measures estradiol (a female hormone) levels in breast cancer patients receiving hormone therapy. It helps doctors understand how well different treatments are working and may guide future care.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.